What Do You Know About Multiple Myeloma?
Do you remember the multiple myeloma research presented at ASCO 2024? Test your knowledge now and see how you rank!
Jul 18, 2024
MEETING BRIEF
ASCO 2024: Multiple Myeloma
The latest news from ASCO 2024 focused on multiple myeloma (MM) including abstracts, features, and helpful conference information.
ASCO 2024 eBook on Multiple Myeloma
ASCO 2024 eBook on Multiple Myeloma
A curated eBook featuring ASCO 2024 multiple myeloma-focused studies, findings, and expert opinions.
High-Dose Melphalan Conditioning Benefits Patients With Multiple Myeloma
High-Dose Melphalan Conditioning Benefits Patients With Multiple Myeloma
High-dose melphalan conditioning confers survival benefits in patients with extramedullary and non-extramedullary multiple myeloma.
Targeted Interventions Benefit African Americans With Multiple Myeloma
Targeted Interventions Benefit African Americans With Multiple Myeloma
African Americans benefit from targeted multiple myeloma interventions.
Multiple Myeloma Linked to Higher Costs & Mortality in Patients Admitted for GI Bleeding
Multiple Myeloma Linked to Higher Costs & Mortality in Patients Admitted for GI Bleeding
Patients with multiple myeloma who were admitted for gastrointestinal bleeding had higher costs and mortality than those without multiple myeloma.
Advertisement
PW QUIZ
Advertisement
Barriers to Care Delay Costly Multiple Myeloma Treatment
Barriers to Care Delay Costly Multiple Myeloma Treatment
Social determinants of health create barriers that delay access to expensive oral anti-myeloma drugs for people with newly diagnosed multiple myeloma.
Examining Mortality in Patients With Multiple Myeloma and the Role of Infectious Diseases
Examining Mortality in Patients With Multiple Myeloma and the Role of Infectious Diseases
Investigators examined the changes in mortality rates due to COVID-19, influenza, and pneumonia in patients with MM.
Examining the Link Between Social Determinants of Time and Health to Treatment for NDMM
Examining the Link Between Social Determinants of Time and Health to Treatment for NDMM
The following is a summary of “Association between social determinants of health and time to...
Examining the Link Between Treatment Patterns and Financial Fragility in Multiple Myeloma
Examining the Link Between Treatment Patterns and Financial Fragility in Multiple Myeloma
The following is a summary of “Association between financial fragility and treatment patterns...
Stay connected to the latest news with Physician’s Weekly
Insights from the leaders in medical research, trending topics in clinical medicine, and perspectives from your colleagues.
Subscribe to our free Newsletters to receive weekly emails, and even get a laugh or two from our medical cartoons.
